Beijing Balance Medical Technology Co (688198) Fair Value & Analysis
Healthcare · CN · Market cap 12.1B CNY
Analysis
Beijing Balance Medical Technology Co (688198) currently trades at ¥84.82, while our model-based Fair Value estimate is ¥25.14 — implying the stock looks roughly 70.4% overvalued today. We read business quality at 94/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patches; bovine pericardial valves, as well as pulmonary artery valved pipeline, outflow tract single flap patches, etc. Its products are used in heart valve replacement and repair, congenital heart disease implant intervention, and surgical soft tissue repair applications; and cardiothoracic surgery, neurosurgery, general surgery, and other surgical departments. Beijing Balance Medical Technology Co.,Ltd. was founded in 2005 and is headquartered in Beijing, China.
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.